Manejeh Yaqub

455 total citations
16 papers, 331 citations indexed

About

Manejeh Yaqub is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Manejeh Yaqub has authored 16 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Manejeh Yaqub's work include Coronary Interventions and Diagnostics (14 papers), Cardiac Imaging and Diagnostics (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Manejeh Yaqub is often cited by papers focused on Coronary Interventions and Diagnostics (14 papers), Cardiac Imaging and Diagnostics (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Manejeh Yaqub collaborates with scholars based in United States, United Kingdom and Switzerland. Manejeh Yaqub's co-authors include Poornima Sood, Gregg W. Stone, Krishnankutty Sudhir, James Hermiller, Robert J. Applegate, Alexandra J. Lansky, Xiaolu Su, Naim Farhat, Donald E. Cutlip and John Wang and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Manejeh Yaqub

15 papers receiving 324 citations

Peers

Countries citing papers authored by Manejeh Yaqub

Since Specialization

Citations

This map shows the geographic impact of Manejeh Yaqub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manejeh Yaqub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manejeh Yaqub more than expected).

Fields of papers citing papers by Manejeh Yaqub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manejeh Yaqub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manejeh Yaqub. The network helps show where Manejeh Yaqub may publish in the future.

Co-authorship network of co-authors of Manejeh Yaqub

This figure shows the co-authorship network connecting the top 25 collaborators of Manejeh Yaqub. A scholar is included among the top collaborators of Manejeh Yaqub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manejeh Yaqub. Manejeh Yaqub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants 2024 ·Ophthalmology and Therapy ·Nancy M. Holekamp, Manejeh Yaqub, Shrirang V. Ranade, Ronald A. Cantrell, (unknown), Gus Gazzard	0
2	Mosunetuzumab in Combination with Lenalidomide Has a Manageable Safety Profile and Encouraging Activity in Patients with Relapsed/Refractory Follicular Lymphoma: Initial Results from a Phase Ib Study 2021 ·Blood ·Franck Morschhauser, Mark Bishton, Toby A. Eyre, Emmanuel Bachy, Guillaume Cartron, Loïc Ysebaert, Sabela Bobillo, Norma C. Gutiérrez, Lihua E. Budde, Christopher P. Fox, Andrea Knapp, Manejeh Yaqub, Michael C. Wei, Carol O’Hear, Haocheng Li, Enkhtsetseg Purev, William Townsend	32
3	Evaluation of XIENCE V Everolimus-Eluting and Taxus Express2 Paclitaxel-Eluting Coronary Stents in Patients With Jailed Side Branches From the SPIRIT IV Trial at 2 Years 2013 ·The American Journal of Cardiology ·John K. Forrest, Alexandra J. Lansky, Stephanie Meller, Liming Hou, Poornima Sood, Robert J. Applegate, John Wang, Kimberly A. Skelding, (unknown), Dean J. Kereiakes, Krishnankutty Sudhir, Ecaterina Cristea, Manejeh Yaqub, Gregg W. Stone	2
4	Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents 2012 ·EuroIntervention ·Robert J. Applegate, James Hermiller, Paul Gordon, Manejeh Yaqub, Poornima Sood, Xiaolu Su, Sherry Cao, Krishnankutty Sudhir, Gregg W. Stone	3
5	Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials 2012 ·EuroIntervention ·James Hermiller, Krishnankutty Sudhir, Robert J. Applegate, Ali A. Rizvi, John Wang, Paul Gordon, Manejeh Yaqub, Sherry Cao, (unknown), Robert S. Smith, Poornima Sood, Gregg W. Stone	4
6	Impact of Routine Angiographic Follow-Up After Percutaneous Coronary Intervention With Drug-Eluting Stents in the SPIRIT III Randomized Trial at Three Years 2012 ·The American Journal of Cardiology ·Alexandra J. Lansky, Somjot Brar, Manejeh Yaqub, Poornima Sood, Robert J. Applegate, Dana Lazar, Ivana Jankovic, James Hermiller, (unknown), Krishnankutty Sudhir, Gregg W. Stone	16
7	Periprocedural Myocardial Infarction in a Randomized Trial of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents 2012 ·Circulation Cardiovascular Interventions ·(unknown), Poornima Sood, Krishnankutty Sudhir, James Hermiller, Liming Hou, Kyoko Hattori, Xiaolu Su, Sherry Cao, John Wang, Robert J. Applegate, Dean J. Kereiakes, Manejeh Yaqub, Gregg W. Stone, Donald E. Cutlip	29
8	Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial 2011 ·EuroIntervention ·James Hermiller, Eugenia Nikolsky, Alexandra J. Lansky, Robert J. Applegate, Mark Sanz, Manejeh Yaqub, Poornima Sood, Sherry Cao, Krishnankutty Sudhir, Gregg W. Stone	14
9	Low Stent Thrombosis Risk with the XIENCE V® Everolimus-Eluting Coronary Stent: Evidence from Randomized and Single-Arm Clinical Trials 2011 ·Journal of Interventional Cardiology ·(unknown), James Hermiller, Alexandra J. Lansky, Manejeh Yaqub, Kyoko Hattori, Sherry Cao, Poornima Sood, (unknown)	8
10	Performance of Everolimus-Eluting versus Paclitaxel-Eluting Coronary Stents in Small Vessels: Results from the SPIRIT III and SPIRIT IV Clinical Trials 2011 ·Journal of Interventional Cardiology ·(unknown), James Hermiller, Manejeh Yaqub, William Newman, Poornima Sood, John Wang, Louis Cannon, James E. Maddux, Krishnankutty Sudhir, Gregg W. Stone	22
11	Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial) 2011 ·The American Journal of Cardiology ·Robert J. Applegate, Manejeh Yaqub, James Hermiller, Poornima Sood, Shui Yu, Julie Doostzadeh, Jerome Williams, Naim Farhat, Ronald Caputo, Alexandra J. Lansky, Donald E. Cutlip, Krishnankutty Sudhir, Gregg W. Stone	30
12	Three-Year Results of Safety and Efficacy of the Everolimus-Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial) 2011 ·The American Journal of Cardiology ·Vivian G. Ng, Alexandra J. Lansky, James Hermiller, Naim Farhat, Robert J. Applegate, Manejeh Yaqub, Poornima Sood, Xiaolu Su, Charles A. Simonton, Krishnankutty Sudhir, Gregg W. Stone	16
13	Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents 2010 ·Journal of the American College of Cardiology ·Dean J. Kereiakes, Donald E. Cutlip, Robert J. Applegate, John Wang, Manejeh Yaqub, Poornima Sood, Xiaolu Su, (unknown), Naim Farhat, Ali A. Rizvi, Charles A. Simonton, Krishnankutty Sudhir, Gregg W. Stone	67
14	Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents 2010 ·JACC: Cardiovascular Interventions ·Adriano Caixeta, Alexandra J. Lansky, Patrick W. Serruys, James Hermiller, Peter Ruygrok, Yoshinobu Onuma, Paul Gordon, Manejeh Yaqub, Karine Miquel‐Hébert, Susan Veldhof, Poornima Sood, Xiaolu Su, (unknown), Krishnankutty Sudhir, Gregg W. Stone	37
15	Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention 2010 ·JACC: Cardiovascular Interventions ·Dean J. Kereiakes, Krishnankutty Sudhir, James Hermiller, Paul Gordon, (unknown), Manejeh Yaqub, Poornima Sood, Xiaolu Su, Steven J. Yakubov, Alexandra J. Lansky, Gregg W. Stone	27
16	Side branch occlusion with everolimus-eluting and paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial 2010 ·EuroIntervention ·Alexandra J. Lansky, Manejeh Yaqub, James Hermiller, Robert S. Smith, Naim Farhat, Ronald Caputo, Jerome Williams, Mark Sanz, (unknown), Poornima Sood, Krishnankutty Sudhir, Gregg W. Stone	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact